Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET
Company Participants
Jack Knight – Vice President, Investor Relations
Dan Burton – Chief Executive Officer
Dan LeSueur – Chief Operating Officer
Jason Alger – Chief Financial Officer
Conference Call Participants
Anne Samuel – JPMorgan
Jared Haase – William Blair
Jessica Tassan – Piper Sandler
Elizabeth Anderson – Evercore ISI
Richard Close – Canaccord Genuity
Daniel Grosslight – Citi
Jenny Shen – BTIG
Scott Schoenhaus – KeyBanc
Stan Berenshteyn – Wells Fargo
Jeff Garro – Stephens
Sarah James – Cantor
Operator
Welcome to the Health Catalyst First Quarter 2025 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. [Operator Instructions]
Now, I would like to turn the conference over to Jack Knight, Vice President of Investor Relations. Please go ahead, sir.
Jack Knight
Good afternoon, and welcome to Health Catalyst’s earnings conference call for the first quarter of 2025, which ended on March 31, 2025.
My name is Jack Knight. I am the Vice President of Investor Relations for Health Catalyst. And with me on the call is Dan Burton, our Chief Executive Officer; Jason Alger, our Chief Financial Officer; and Dan LeSueur, our Chief Operating Officer.
A complete disclosure of our results can be found in our press release issued today as well as in our related Form 8-K furnished to the SEC, both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com.
As a reminder, today’s call is being recorded, and a replay will be available following the conclusion of the call.
During today’s call, we will make forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform
#Health #Catalyst #HCAT #Earnings #Call #Transcript